Key result
Double stenting for bifurcation lesions linked to ~27% higher 3-year MACE risk vs single stenting.
Why the study?
Current outcome data for percutaneous coronary intervention in coronary bifurcation lesions have shown varying results, and long-term outcomes comparing single versus double stenting strategies remain largely unexplored.
Does a double stenting strategy compared to a single stenting strategy affect the risk of major adverse cardiac events at 3 years in patients undergoing percutaneous coronary intervention for coronary bifurcation lesions?
Cohort (n=3,991)
No
Does a double stenting strategy compared to a single stenting strategy affect the risk of major adverse cardiac events at 3 years in patients undergoing percutaneous coronary intervention for coronary bifurcation lesions?
In a large cohort of patients undergoing PCI for coronary bifurcation lesions, a single stenting strategy was associated with a significantly lower 3-year risk of MACE compared to a double stenting strategy.
May favor single stenting in bifurcation PCI to lower MACE risk; leaves open confirmation by randomized trials.
Background The coronary bifurcation lesion remains a unique challenge for the modern interventionalist. Current outcome data in treatment of bifurcation lesions have shown varying results. Additionally, long-term outcomes remain largely unexplored. Purpose The main objective of this study is to investigate and compare the long-term outcome of patients after percutaneous coronary interventions in bifurcation lesions in single versus double stenting strategies in a large volume center. Methods We analyzed 3991 patients from a large registry undergoing percutaneous coronary interventions for bifurcation lesions for over 3 years. Primary endpoint was major adverse cardiac events (MACE) consisting of all cause death, myocardial infarction, or target lesion revascularization. Survival analysis with weighted Kaplan-Meier curves and Cox proportional hazard models were constructed. Results Double stenting was associated with a significantly higher risk of MACE at three years with a hazard ratio of 1.27 (95% CI 1.08–1.50). Survival analysis has shown a superior outcome in terms of occurrence of MACE in single stenting versus double stenting (P<0.01). Subgroup analysis has shown an amplified risk in higher degree of calcification (hazard ratio 1.42; 95% CI 1.12–1.79) and side branch ostial involvement (hazard ratio HR 1.30; 95% CI 1.08–1.56). Conclusions Our large cohort has shown that single stenting strategies was associated with significantly better outcome than double stenting strategies.
No takes yet. Share an insight, caveat, or question.
Laohachewin et al. (2026) conducted a cohort in Coronary bifurcation lesions undergoing percutaneous coronary intervention (n=3,991). Double stenting strategy vs. Single stenting strategy was evaluated on Major adverse cardiac events (MACE), defined as all-cause death, myocardial infarction, or target lesion revascularization at 3 years (HR 1.27, 95% CI 1.08-1.50, p=<0.01). Double stenting for coronary bifurcation lesions was associated with a higher 3-year risk of MACE compared to single stenting (HR 1.27; 95% CI 1.08–1.50; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: